FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W3006182009> ?p ?o ?g. }

• W3006182009 abstract "Immunity has emerged as a key player in neurodegenerative diseases such as amyotrophic lateral sclerosis, with recent studies documenting aberrant immune changes in patients and animal models. A challenging aspect of amyotrophic lateral sclerosis research is the heterogeneous nature of the disease. In this study, we investigate the associations between peripheral blood myeloid cell populations and clinical features characteristic of amyotrophic lateral sclerosis. Peripheral blood leukocytes from 23 healthy controls and 48 patients with amyotrophic lateral sclerosis were analysed to measure myeloid cell alterations. The proportion of monocytes (classical, intermediates and non-classical subpopulations) and neutrophils, as well as the expression of select surface markers, were quantitated using flow cytometry. Given the heterogeneous nature of amyotrophic lateral sclerosis, multivariable linear analyses were performed to investigate associations between patients' myeloid profile and clinical features, such as the Revised Amyotrophic Lateral Sclerosis Functional Rating Scale, bulbar subscore of the Revised Amyotrophic Lateral Sclerosis Functional Rating Scale, change in Revised Amyotrophic Lateral Sclerosis Functional Rating Scale over disease duration and respiratory function. We demonstrate a shift in monocyte subpopulations in patients with amyotrophic lateral sclerosis, with the ratio of classical to non-classical monocytes increased compared with healthy controls. In line with this, patients with greater disease severity, as determined by a lower Revised Amyotrophic Lateral Sclerosis Functional Rating Scale score, had reduced non-classical monocytes. Interestingly, patients with greater bulbar involvement had a reduction in the proportions of classical, intermediate and non-classical monocyte populations. We also revealed several notable associations between myeloid marker expression and clinical features in amyotrophic lateral sclerosis. CD16 expression on neutrophils was increased in patients with greater disease severity and a faster rate of disease progression, whereas HLA-DR expression on all monocyte populations was elevated in patients with greater respiratory impairment. This study demonstrates that patients with amyotrophic lateral sclerosis with distinct clinical features have differential myeloid cell signatures. Identified cell populations and markers may be candidates for targeted mechanistic studies and immunomodulation therapies in amyotrophic lateral sclerosis." @default.
• W3006182009 created "2020-02-24" @default.
• W3006182009 creator A5017869363 @default.
• W3006182009 creator A5025117056 @default.
• W3006182009 creator A5030694727 @default.
• W3006182009 creator A5038700827 @default.
• W3006182009 creator A5048588036 @default.
• W3006182009 creator A5053813248 @default.
• W3006182009 creator A5055017065 @default.
• W3006182009 creator A5079833878 @default.
• W3006182009 creator A5088801325 @default.
• W3006182009 date "2020-01-01" @default.
• W3006182009 modified "2023-10-14" @default.
• W3006182009 title "Monocytes and neutrophils are associated with clinical features in amyotrophic lateral sclerosis" @default.
• W3006182009 cites W1959858628 @default.
• W3006182009 cites W1962864834 @default.
• W3006182009 cites W1974240968 @default.
• W3006182009 cites W1979375317 @default.
• W3006182009 cites W1984378291 @default.
• W3006182009 cites W1994509353 @default.
• W3006182009 cites W1996973828 @default.
• W3006182009 cites W2028097575 @default.
• W3006182009 cites W2054637685 @default.
• W3006182009 cites W2058742494 @default.
• W3006182009 cites W2059833361 @default.
• W3006182009 cites W2060116667 @default.
• W3006182009 cites W2065627672 @default.
• W3006182009 cites W2065954963 @default.
• W3006182009 cites W2066837213 @default.
• W3006182009 cites W2086639871 @default.
• W3006182009 cites W2098613848 @default.
• W3006182009 cites W2108381339 @default.
• W3006182009 cites W2119656827 @default.
• W3006182009 cites W2142648440 @default.
• W3006182009 cites W2161938104 @default.
• W3006182009 cites W2190014693 @default.
• W3006182009 cites W2283963041 @default.
• W3006182009 cites W2408832111 @default.
• W3006182009 cites W2519980608 @default.
• W3006182009 cites W2582971006 @default.
• W3006182009 cites W2585456590 @default.
• W3006182009 cites W2607829140 @default.
• W3006182009 cites W2738348227 @default.
• W3006182009 cites W2741191987 @default.
• W3006182009 cites W2761403361 @default.
• W3006182009 cites W2792497181 @default.
• W3006182009 cites W2803148268 @default.
• W3006182009 cites W2911407981 @default.
• W3006182009 cites W4252979096 @default.
• W3006182009 doi "https://doi.org/10.1093/braincomms/fcaa013" @default.
• W3006182009 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/7530830" @default.
• W3006182009 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/33033799" @default.
• W3006182009 hasPublicationYear "2020" @default.
• W3006182009 type Work @default.
• W3006182009 sameAs 3006182009 @default.
• W3006182009 citedByCount "24" @default.
• W3006182009 countsByYear W30061820092020 @default.
• W3006182009 countsByYear W30061820092021 @default.
• W3006182009 countsByYear W30061820092022 @default.
• W3006182009 countsByYear W30061820092023 @default.
• W3006182009 crossrefType "journal-article" @default.
• W3006182009 hasAuthorship W3006182009A5017869363 @default.
• W3006182009 hasAuthorship W3006182009A5025117056 @default.
• W3006182009 hasAuthorship W3006182009A5030694727 @default.
• W3006182009 hasAuthorship W3006182009A5038700827 @default.
• W3006182009 hasAuthorship W3006182009A5048588036 @default.
• W3006182009 hasAuthorship W3006182009A5053813248 @default.
• W3006182009 hasAuthorship W3006182009A5055017065 @default.
• W3006182009 hasAuthorship W3006182009A5079833878 @default.
• W3006182009 hasAuthorship W3006182009A5088801325 @default.
• W3006182009 hasBestOaLocation W30061820091 @default.
• W3006182009 hasConcept C142724271 @default.
• W3006182009 hasConcept C203014093 @default.
• W3006182009 hasConcept C2779134260 @default.
• W3006182009 hasConcept C2779282312 @default.
• W3006182009 hasConcept C2780596555 @default.
• W3006182009 hasConcept C71924100 @default.
• W3006182009 hasConcept C8891405 @default.
• W3006182009 hasConceptScore W3006182009C142724271 @default.
• W3006182009 hasConceptScore W3006182009C203014093 @default.
• W3006182009 hasConceptScore W3006182009C2779134260 @default.
• W3006182009 hasConceptScore W3006182009C2779282312 @default.
• W3006182009 hasConceptScore W3006182009C2780596555 @default.
• W3006182009 hasConceptScore W3006182009C71924100 @default.
• W3006182009 hasConceptScore W3006182009C8891405 @default.
• W3006182009 hasFunder F4320313097 @default.
• W3006182009 hasFunder F4320314730 @default.
• W3006182009 hasFunder F4320321995 @default.
• W3006182009 hasFunder F4320334705 @default.
• W3006182009 hasIssue "1" @default.
• W3006182009 hasLocation W30061820091 @default.
• W3006182009 hasLocation W30061820092 @default.
• W3006182009 hasLocation W30061820093 @default.
• W3006182009 hasOpenAccess W3006182009 @default.
• W3006182009 hasPrimaryLocation W30061820091 @default.
• W3006182009 hasRelatedWork W1999554465 @default.
• W3006182009 hasRelatedWork W2048256717 @default.
• W3006182009 hasRelatedWork W2070831599 @default.
• W3006182009 hasRelatedWork W2393752460 @default.
• W3006182009 hasRelatedWork W2590675198 @default.

• next